Results 141 to 142 of about 41,221 (142)
Some of the next articles are maybe not open access.

Safety and clinical outcomes of pembrolizumab standard-interval dosing versus extended-interval dosing in patients with breast cancer Open Access

Oncologist
Alexis Levee   +2 more
exaly  

JC virus or extended interval dosing? More data are needed

Multiple Sclerosis Journal
openaire   +2 more sources
multiple sclerosis
natalizumab
diseases of the nervous system
pharmacokinetics
neurology
pharmacology
therapeutics
dupilumab
previous   13  14  15  

Home - About - Disclaimer - Privacy